In fiscal year 2025, INVITES BIOCORE (216400) reported revenue of 16.6 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 16.6 billion KRW | 218 million KRW | -8.3 billion KRW | [source] |
| 2024 | 21.6 billion KRW | 326 million KRW | -10.8 billion KRW | [source] |
| 2023 | 22.3 billion KRW | -5.3 billion KRW | -8.2 billion KRW | — |
| 2022 | 25.4 billion KRW | 2.8 billion KRW | -2.5 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 62.5 billion KRW | 59.9 billion KRW | 2.7 billion KRW | [source] |
| 2024 | 93.2 billion KRW | 62.9 billion KRW | 30.3 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.